Mediclin AG

Total Valuation

Mediclin AG carries a market capitalization of 197.60M, placing it among publicly traded companies globally. Its enterprise value stands at 472.13M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

Mediclin AG currently has 47.50M shares outstanding.

Valuation Ratios

Mediclin AG trades at a trailing price-to-earnings ratio of 4.34. The price-to-sales ratio is 0.20, and the price-to-book ratio stands at 1.92.

Enterprise Valuation

On an enterprise value basis, Mediclin AG trades at an EV/EBITDA multiple of 6.48 and an EV/FCF ratio of 2.88. The EV/Sales ratio of 0.61 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 6.48 provides insight into valuation relative to core operating earnings.

Financial Position

Mediclin AG maintains a current ratio of 1.93, meaning it holds 1.9x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 180.48, indicating elevated leverage, while an interest coverage ratio of 3.23 demonstrates adequate ability to service its debt obligations.

Financial Efficiency

Mediclin AG posts a return on equity of 55.99 and a return on invested capital of 7.74.

Taxes

Over the trailing twelve months, Mediclin AG has paid 12.01M in income taxes, reflecting an effective tax rate of 25.40.

Stock Price Statistics

Mediclin AG's stock has gained approximately 40.54054% over the past 52 weeks. The 50-day moving average sits at 3.54, while the 200-day moving average is 3.53.

Income Statement

Over the trailing twelve months, Mediclin AG generated 769.55M in revenue and converted that into 35.05M in net income, yielding earnings per share of 0.73. EBITDA reached 72.88M, while operating income came in at 72.88M.

Balance Sheet

Mediclin AG holds 128.22M in cash and equivalents against 447.78M in total debt, resulting in a net debt position of -51.90M. Total book value stands at 79.18M, with working capital of 153.41M providing operational flexibility.

Cash Flow

Mediclin AG produced 96.67M in operating cash flow over the past twelve months. After subtracting -50.17M in capital expenditures, free cash flow totaled 46.50M - equivalent to 0.96 per share.

Margins

Mediclin AG operates with a gross margin of 84.07, reflecting its pricing power and cost economics. The operating margin of 9.47 and net profit margin of 4.55 provide insight into operational efficiency.

Dividends & Yields

Scores

Mediclin AG posts an Altman Z-Score of 1.54, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.